World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 95 10190 9563 362 346 487 27384

Andrés J.M. Ferreri publications per year

The chart shows the history of publications by Andrés J.M. Ferreri between 1993 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Andrés J.M. Ferreri published across 33 years, from 1993 to 2025, averaging 19.9 papers a year. Output peaked at 96 publications in 2023. 103 of the 656 publications appeared in the last two years.

No. of publications
20 40 60 80
Bar chart. Horizontal axis: year, 1993 to 2025. Vertical axis: number of publications, 0 to 96. Peak 96 publications in 2023. 1993: 1 publication 1994: 0 publications 1995: 3 publications 1996: 3 publications 1997: 2 publications 1998: 3 publications 1999: 8 publications 2000: 8 publications 2001: 11 publications 2002: 5 publications 2003: 12 publications 2004: 10 publications 2005: 7 publications 2006: 11 publications 2007: 19 publications 2008: 25 publications 2009: 17 publications 2010: 15 publications 2011: 28 publications 2012: 27 publications 2013: 28 publications 2014: 24 publications 2015: 26 publications 2016: 18 publications 2017: 21 publications 2018: 21 publications 2019: 24 publications 2020: 16 publications 2021: 33 publications 2022: 31 publications 2023: 96 publications 2024: 29 publications 2025: 74 publications
1993 2025

656 publications in total across all disciplines

View publications per year as a table
Andrés J.M. Ferreri: publications per year, 1993 to 2025
Year Publications
1993 1
1994 0
1995 3
1996 3
1997 2
1998 3
1999 8
2000 8
2001 11
2002 5
2003 12
2004 10
2005 7
2006 11
2007 19
2008 25
2009 17
2010 15
2011 28
2012 27
2013 28
2014 24
2015 26
2016 18
2017 21
2018 21
2019 24
2020 16
2021 33
2022 31
2023 96
2024 29
2025 74
Total 656
Download as CSV

Andrés J.M. Ferreri publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Andrés J.M. Ferreri sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 481–500 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 487 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713 487
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Andrés J.M. Ferreri D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Andrés J.M. Ferreri sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 94–95 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808 95
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Andrés J.M. Ferreri is affiliated with Vita-Salute San Raffaele University in Italy. Their research primarily spans the field of Medicine, with a focus on several key subfields including Pathology and Forensic Medicine, Oncology, Genetics, Neurology, and Immunology. The scientist's work centers heavily on lymphoma, particularly on its diagnosis and treatment, as well as research on chronic lymphocytic leukemia and CAR-T cell therapy.

Their scholarly contributions include a significant number of publications in notable venues such as Hematological Oncology, Blood, Blood Advances, British Journal of Haematology, and UNC Libraries. Frequent coauthors in their research include Maurilio Ponzoni, Teresa Calimeri, Carlo Visco, Emanuele Zucca, and Luca Arcaini.

Among the recent papers authored or coauthored by Andrés J.M. Ferreri are:

  • Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial (2021, Nature Medicine)
  • Primary central nervous system lymphoma (2023, Nature Reviews Disease Primers)
  • Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG) (2021, Neuro-Oncology)
  • Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial (2022, Leukemia)
  • European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL) (2022, Neuro-Oncology)

The main topics addressed across Andrés J.M. Ferreri's body of work include:

  • Lymphoma Diagnosis and Treatment
  • CNS Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • CAR-T cell therapy research
  • Glioma Diagnosis and Treatment
  • Viral-associated cancers and disorders
  • Immune Cell Function and Interaction

These research interests are closely linked to their multidisciplinary expertise in related medical and biological sciences, integrating clinical approaches with immunological and genetic perspectives. The scientist's publication record reflects ongoing contributions to the advancement of understanding and treating complex hematological malignancies and neurological cancers.

Best Publications

  • Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience

    Andrés J M Ferreri;Jean Yves Blay;Michele Reni;Felice Pasini

  • High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

    Andrés J. M. Ferreri;Michele Reni;Marco Foppoli;Maurizio Martelli

  • Evidence for an Association Between Chlamydia psittaci and Ocular Adnexal Lymphomas

    Andrés J. M. Ferreri;Massimo Guidoboni;Maurilio Ponzoni;Carlo De Conciliis

  • Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.

    Emanuele Zucca;Annarita Conconi;Ennio Pedrinis;Sergio Cortelazzo

  • Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.

    Andrés J M Ferreri;Kate Cwynarski;Elisa Pulczynski;Maurilio Ponzoni

  • MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

    Shimin Hu;Zijun Y. Xu-Monette;Alexander Tzankov;Tina Green

  • Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus Meeting

    Maurilio Ponzoni;Andrés J.M. Ferreri;Elías Campo;Fabio Facchetti

  • Diffuse large B-cell lymphoma.

    Maurizio Martelli;Andrés J.M. Ferreri;Claudio Agostinelli;Alice Di Rocco

  • Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

    Annarita Conconi;Giovanni Martinelli;Catherine Thiéblemont;Andrés J M Ferreri

  • Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

    Zijun Y. Xu-Monette;Lin Wu;Carlo Visco;Yu Chuan Tai

  • Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology

    Khê Hoang-Xuan;Eric Bessell;Jacoline Bromberg;Andreas F Hottinger

  • Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

    Andres J. M. Ferreri;Kate Cwynarski;Elisa Pulczynski;Christopher P. Fox

  • Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy.

    Giovanni Martinelli;Daniele Laszlo;Andrés J M Ferreri;Giancarlo Pruneri

  • Summary Statement on Primary Central Nervous System Lymphomas From the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002

    Andrés J.M. Ferreri;Lauren E. Abrey;Jean Yves Blay;Bettina Borisch

  • Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma)

    Markus Raderer;Barbara Kiesewetter;Andrés J. M. Ferreri

  • Primary CNS Lymphoma of T-Cell Origin: A Descriptive Analysis From the International Primary CNS Lymphoma Collaborative Group

    Tamara N. Shenkier;Jean Yves Blay;Brian Patrick O'Neill;Philip Poortmans

  • Regression of Ocular Adnexal Lymphoma After Chlamydia Psittaci–Eradicating Antibiotic Therapy

    Andrés J M Ferreri;Maurilio Ponzoni;Massimo Guidoboni;Carlo De Conciliis

  • First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial

    Umberto Vitolo;Annalisa Chiappella;Andrés J.M. Ferreri;Maurizio Martelli

  • Induction chemotherapy stategies for primary mediastinal large B-cell lymphoma with sclerosis: A retrospective multinational study on 426 previously untreated patients

    Pier Luigi Zinzani;Maurizio Martelli;Marilena Bertini;Alessandro M Gianni

  • Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

    Carlo Visco;Alexander Tzankov;Zijun Y. Xu-Monette;Roberto N. Miranda

Frequent Co-Authors

Maurilio Ponzoni
Maurilio Ponzoni Vita-Salute San Raffaele University
Emanuele Zucca
Emanuele Zucca Universita della Svizzera Italiana
Miguel A. Piris
Miguel A. Piris Instituto de Salud Carlos III
Govind Bhagat
Govind Bhagat Columbia University
Eric D. Hsi
Eric D. Hsi Cleveland Clinic
Claudio Doglioni
Claudio Doglioni Vita-Salute San Raffaele University
Youli Zu
Youli Zu Houston Methodist
L. Jeffrey Medeiros
L. Jeffrey Medeiros The University of Texas MD Anderson Cancer Center
Michele Reni
Michele Reni Vita-Salute San Raffaele University
Santiago Montes-Moreno
Santiago Montes-Moreno Instituto de Investigación Marqués de Valdecilla

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine isn’t limited to becoming a doctor. A variety of online degrees and accelerated career paths in healthcare are gaining popularity, offering flexible options for students from all backgrounds.

Those interested in administrative roles may consider enrolling in healthcare administration accelerated degree programs. These offer quick, focused training for leadership positions in medical facilities.

For students wanting to work in clinical settings without years of schooling, nursing programs present various entry points. You can pursue rn to fnp programs if you wish to advance from an associate degree in nursing to a nurse practitioner role. If you’re concerned about entrance exams, there are nursing school that don't require teas or HESI exams, eliminating a common barrier.

Additionally, non-clinical fields like medical billing and coding can be a fast route to employment, with many medical billing and coding online schools that accept financial aid making the required credential accessible to most students.

These alternative degrees and career pathways can help you enter the healthcare field quickly, often with less financial and time investment compared to traditional medical programs.

Best Scientists Citing Andrés J.M. Ferreri

Trending Scientists

Recently Published Articles